Janus kinase 2 V617F mutation in an unrelated peripheral blood stem cell donor
Polycythemia vera (PV) is relatively uncommon in early adulthood, and evidence about the prevalence of the Janus kinase 2 (JAK2) V617F mutation in the general population is limited. Here, we report a previously healthy volunteer peripheral blood stem cell (PBSC) donor who developed symptomatic PV wi...
Main Authors: | Shang-Hsien Yang, Hsiang-Lin Wan, Ming-Hui Gu, Tso-Fu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Tzu-Chi Medical Journal |
Subjects: | |
Online Access: | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2019;volume=31;issue=1;spage=60;epage=62;aulast=Yang |
Similar Items
-
Detection of JAK2V617F tyrosine kinase mutation and estimation of serum erythropoietin in blood donors who have high hematocrit
by: Haythem A. AL-Rubaie, et al.
Published: (2015-01-01) -
Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012-06-01) -
Analysis of JAK2V617F Tyrosine Kinase Mutation in Blood Donors with Erythrocytosis – A Pilot Study in a Tertiary Care Teaching Hospital of South India
by: Gaddam M, et al.
Published: (2022-08-01) -
Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm
by: Shuchi Ghai, et al.
Published: (2017-01-01) -
JAK2 p.V617F Variants in Non-Blood DNA from Patients with Polycythemia Vera
by: Naoki Mori, et al.
Published: (2023-08-01)